Keros Therapeutics, Inc.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2019 | $-6.08 | $-7.46 |
| FY2020 | $-2.93 | $-5.51 |
| FY2021 | $-2.52 | $-4.64 |
| FY2022 | $-4.15 | $-4.59 |
| FY2023 | $-5.20 | $-4.75 |
| FY2024 | $-5.00 | $-4.79 |
| FY2025 | $2.30 | $-3.78 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2019 | $-6.08 | $-7.46 |
| FY2020 | $-2.93 | $-5.51 |
| FY2021 | $-2.52 | $-4.64 |
| FY2022 | $-4.15 | $-4.59 |
| FY2023 | $-5.20 | $-4.75 |
| FY2024 | $-5.00 | $-4.79 |
| FY2025 | $2.30 | $-3.78 |